J&J to invest as much as $13M in Enlight Biosciences

01/22/2009 | Xconomy

Johnson & Johnson became the latest major firm to partner with Enlight Biosciences, joining the ranks of Eli Lilly and Co., Merck & Co. and Pfizer. Enlight strives to find technology in areas such as molecular imaging that could help in drug discovery and development. A J&J official said the project will help the drugmaker "identify technology needs and influence future industry standards."

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care